- 暂无内容
- . A novel drug combination of Tofacitinib and Iguratimod alleviates rheumatoid arthritis and secondary osteoporosis. International Immunopharmacology 201, 124, 2024.
- . Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity.. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF T, 119, e2117054119, 2023.
- 孙姣. Galectin-9 expression correlates with therapeutic effect in rheumatoid arthritis. Scientific reports, 11, 2022.
- 李洁. Iguratimod: a valuable remedy from the Asia Pacific region for ameliorating autoimmune diseases and protecting bone physiology. BONE RESEARCH, 7, 2021.
- 暂无内容
- 暂无内容
- 贝利尤单抗在中国系统性红斑狼疮患者中的真实世界效果研究, 2023/12/08-2026/12/31
- 乏氧培养的人脐带间充质干细胞（MSC）治疗类风湿关节炎合并肺间质病变动物模型的疗效和安全性及作用机制的研究, 2022/12/02-2024/05/31
- 强直性脊柱炎患者生物制剂治疗应答与免疫细胞变化的研究, 2022/11/11-2024/06/30
- 利妥昔单抗续贯泰它西普治疗系统性红斑狼疮继发抗磷脂综合症的有效性和安全性临床研究, 2023/02/06-2023/10/30
- （包干项目）Galectin-9在 RA 中对TNF-a介导 FLS 焦亡的调控作用研究, 2022/11/01-2025/12/30
- 暂无内容